Why GLP-1 users track more than calories A GLP-1 routine has more moving parts than a diet: a weekly shot or daily pill, dose increases every few weeks, and side effects that follow the schedule
Petrelintide, developed by Zealand Pharma, is a once-weekly, long-acting analog structurally similar to cagrilintide and is being evaluated in a phase 2 trial (ZUPREME-1) for obesity treatment
Should I try a weight loss patch for my New Year resolution
Before starting GLP-1 therapy, a healthcare provider will carefully review your medical history to ensure its a safe option for you
Heart failure (HF) affects approximately 6 million people in the US, with projections estimating a 46% increase in prevalence from 2012 to 2030
These changes are often more pronounced than Botox or filler because they are structural (actual collagen remodeling) rather than paralysis or filling